Element to Present Data and Innovation Roadmap at AGBT
Retrieved on:
Monday, February 6, 2023
Cloud, Sequence, ECP, House, Q&A, Workflow, Biochemistry, SVP, Manhattan Center, Hi-C (genomic analysis technique), Q42, Elevate, Mass meeting, Avidity, Chemistry, SAN, Innovation, Grande Ballroom, Genomics, John J. Carty Award for the Advancement of Science, Overalls, Great hall, Genome, Doctor of Philosophy, Fine chemical, Management, Element, Tavarua, Informatics, Software, Q40
SAN DIEGO, Feb. 6, 2023 /PRNewswire/ -- Element Biosciences, Inc.— the developer of an innovative DNA sequencing platform disrupting genomics — will present details about its new Avidity Cloudbreak™ technology and the company's innovation roadmap at the Advances in Genome Biology and Technology (AGBT) General Meeting Feb. 6-9, 2023, in Hollywood, FL.
Key Points:
- Element provides the highest quality sequencing on a benchtop for as low as $200 a genome, or $2 per gigabase.
- Element will present customer data on exome sequencing reporting the majority of bases on AVITI are >Q42, the first commercial platform consistently delivering data quality in excess of Q40.
- Join Element for a series of talks at AGBT, including:
Jon Armstrong, VP of Research & Development, Jumpcode Genomics, will present "Boost your single cell studies with CRISPRclean and AVITI: Sequence less and see more usable data." - Matthew Kellinger, PhD, Element VP of Biochemistry and Co-Founder, will present data on Element's technology and future outlook in an AGBT Bronze Workshop talk, "Cloudbreak and Beyond: A Roadmap for Innovation" at 2:40 p.m. in the Grand Ballroom.